PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Stem Cell Therapeutics and Imaging (CSTI), Harvard Medical School, Boston, Massachusetts, USA.\', \'Department of Neurosurgery, Brigham and Women\'s Hospital, Harvard Medical School, Boston, Massachusetts, USA.\', \'Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.\', \'Gastroenterology Unit, Department of Medicine, A.O.U.I. Policlinico G.B. Rossi & University of Verona, Verona, Italy.\', \'Laboratory of Cellular Therapy, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.\', \'Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/stem.3354
?:doi
?:hasPublicationType
?:journal
  • Stem cells (Dayton, Ohio)
is ?:pmid of
?:pmid
?:pmid
  • 33586320
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all